Jefferies Financial Group restated their buy rating on shares of Treatt (LON:TET – Free Report) in a research note issued to investors on Friday, Marketbeat reports. They currently have a GBX 650 ($8.28) price target on the stock.
Treatt Trading Down 0.1 %
Shares of TET opened at GBX 475 ($6.05) on Friday. The stock has a market capitalization of £288.42 million, a P/E ratio of 2,638.89 and a beta of 1.02. Treatt has a twelve month low of GBX 365.29 ($4.66) and a twelve month high of GBX 570 ($7.26). The company has a quick ratio of 0.87, a current ratio of 2.83 and a debt-to-equity ratio of 8.82. The firm has a fifty day simple moving average of GBX 452.39 and a two-hundred day simple moving average of GBX 453.95.
Treatt Increases Dividend
The company also recently announced a dividend, which will be paid on Thursday, March 13th. Stockholders of record on Thursday, February 6th will be issued a dividend of GBX 5.81 ($0.07) per share. This is a positive change from Treatt’s previous dividend of $2.60. This represents a dividend yield of 1.26%. The ex-dividend date of this dividend is Thursday, February 6th. Treatt’s dividend payout ratio is currently 4,444.44%.
About Treatt
Treatt plc, together with its subsidiaries, manufactures and supplies various natural extracts and ingredients to the flavor, fragrance, beverage, and consumer product industries in the United Kingdom, Germany, Ireland, the United States, China, and internationally. The company offers flavor ingredients, such as citrus, coffee, tea, health and wellness, and fruits and vegetables extracts; Hics, aroma, and herb, spice, and floral ingredients.
See Also
- Five stocks we like better than Treatt
- Best Aerospace Stocks Investing
- Guidewire Software Provides Long-Awaited Buying Opportunity
- How to Use the MarketBeat Dividend Calculator
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- Comparing and Trading High PE Ratio Stocks
- Fast-Growing Companies That Are Still Undervalued
Receive News & Ratings for Treatt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Treatt and related companies with MarketBeat.com's FREE daily email newsletter.